CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that Sudhir Agrawal, D. Phil., Chief Executive Officer and Chief Scientific Officer, will participate in a biotechnology discussion panel during the Second Annual SIGnificant Investment Options in Healthcare Conference taking place at The W Hotel in New York City March 4-5, 2008.
